Accelerated Development Facilities Personnel Deep Expertise Faster to Market Faster, Proven Solutions for your Breakthrough Designation and Orphan Drugs Accelerated regulatory pathways of fast track and breakthrough designations can often shave years off the approval process. Accelerating the development and approval of many drugs is often in everyone’s interest, especially when the drug in question is to treat a rare or life-threatening disease. We have integrated solutions from development to commercialization and in-house efficiencies to help ensure your project success. Development-and-Analytical-Services Integrated Solutions Fully integrated services from development, analytical, clinical supply and niche commercial manufacturing. Deep Expertise A proven track record of orphan, break-through and fast-track and accelerated development projects Faster to Market Highly-efficient in-house services to accelerate the process from molecule to final drug product.